Company profile for Candid Therapeutics

Candid Therapeutics

Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

Contact Supplier

DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Contact Supplier

pharmacompass-1-m-2025-12-22

Contact Supplier

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

Contact Supplier

HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

Contact Supplier

pharmacompass-2-m-2025-11-03

Contact Supplier

VISIT THE VIRTUAL BOOTH
Review portfolio & marketing content
CONTACT DETAILS
Google Map, LinkedIn, Emails...

DIGITAL CONTENT

8 News #PharmaBuzz

media
8 News #PharmaBuzz

DEVELOPMENTS

10 Drugs in Development

10 Drugs in Development

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Candid Therapeutics is pioneering a new frontier in autoimmune therapy with its innovative T-cell engager antibodies. By precisely directing T-cells to target and eliminate autoreactive B-cells, we aim to deliver transformative efficacy with enhanced safety. Our approach is rooted in rigorous scientific research and a deep understanding of immunological mechanisms, allowing us to develop therapies that offer significant advanc...

Candid Therapeutics is pioneering a new frontier in autoimmune therapy with its innovative T-cell engager antibodies. By precisely directing T-cells to target and eliminate autoreactive B-cells, we aim to deliver transformative efficacy with enhanced safety. Our approach is rooted in rigorous scientific research and a deep understanding of immunological mechanisms, allowing us to develop therapies that offer significant advancements in the treatment of autoimmune diseases. Candid Therapeutics is committed to pushing the boundaries of immunotherapy to improve patient outcomes.

DCAT WeekDCAT Week

Not Confirmed

Not Confirmed

23-26 March, 2026

New York, U.S.A
BIO Partnering at JPMBIO Partnering at JPM

Not Confirmed

Not Confirmed

12-15 January, 2026

San Francisco Marriott Marquis, California
Biotech ShowcaseBiotech Showcase

Not Confirmed

Not Confirmed

12-14 January, 2026

San Diego, California, U.S.A

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown

United_States_of_America Flag

Country

Country

U.S.A

Address

Address

11622 El Camino Real, Suite 150 San Diego, CA 92130

Telephone

Telephone

Email

enquiries@pharmacompass.com

Client Website

Website

https://www.candidrx.com/

Linkedin

youtube

YouTube

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

Candid Therapeutics Named 2025 Endpoints 11 Honoree

19 Sep 2025

// PHARMAWEB

Candid Therapeutics to Present in Investor & Policy Conferences

28 Aug 2025

// BUSINESSWIRE

Candid Moves T-Cell Engagers Into Autoimmune Trials

20 Jun 2025

// BUSINESSWIRE

Candid steps up TCE deal momentum with $925M WuXi partnership

07 Jan 2025

// BUSSINESSWIRE

Candid Therapeutics & Ab Studio Collaborate on T-Cell Engagers

16 Dec 2024

// BUSINESSWIRE

Candid Therapeutics & EpimAb Collaborate on T-Cell Engagers

16 Dec 2024

// BUSINESSWIRE

Drugs in Development

Full Screen View

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

ABOUT THIS PAGE

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Market Place

Home

Menu

Post Enquiry

Market Place

Search